# A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human

> **NCT05836805** · PHASE1 · UNKNOWN · sponsor: **Xuanzhu Biopharmaceutical Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]XZP-3621

## Key facts

- **NCT ID:** NCT05836805
- **Lead sponsor:** Xuanzhu Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05
- **Primary completion:** 2023-08
- **Final completion:** 2023-09
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836805, "A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05836805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*